This ReadyRx review starts with the number ReadyRx refuses to print: its own price. Product pages literally show $XXX placeholders until you create an account. Per third-party pricing reports, compounded semaglutide runs $299 per month — or $249/mo if you prepay three months at $747 upfront. Tirzepatide is $399/mo, no discount. The headline pitch is a 5%-or-refund guarantee: lose less than 5% of your body weight in 28 weeks as prescribed, and you get your money back. We score ReadyRx 7.2/10 (Good) — real lab-testing receipts and a real guarantee, dragged down by a pricing wall and text-only support.
ReadyRx in 60 Seconds
ReadyRx is a cash-pay telehealth platform operated by Executive Medical, LLC of Cheyenne, Wyoming. It has been in business since 2022, which makes it older than much of the compounded-GLP-1 crowd. The core products are compounded semaglutide and compounded tirzepatide injections, with brand-name Ozempic and Zepbound referenced on its treatment pages.
Let’s say the required thing plainly: compounded GLP-1s are not FDA-approved products. ReadyRx’s own site discloses this, which earns it a point for honesty most rivals skip. It also sells a side menu of longevity prescriptions — NAD+, sermorelin, metformin, glutathione, and MIC+B12 — an unusual catalog for a weight-loss shop.
ReadyRx Review Scorecard
| Fact | Detail |
|---|---|
| Our score | 7.2/10 — Good |
| Operator | Executive Medical, LLC, Cheyenne, WY — in business since 2022 |
| Semaglutide price | $299/mo, or $249/mo with 3-month prepay, per third-party reports |
| Tirzepatide price | $399/mo — no multi-month discount |
| Price transparency | $XXX placeholders on product pages until signup |
| Guarantee | Full refund if you lose under 5% after 28 weeks as prescribed |
| Trustpilot | ~4.7-4.8/5, but on only ~65 reviews, per Med Consumer Watch |
| BBB | Not accredited; delivery and service complaints on file |
| Support | Text and messaging only — no phone, no video |
| Insurance | None — 100% cash-pay |
Why 7.2 and not higher? The guarantee, the certificate-of-analysis lab testing, and flat all-dose pricing are genuinely strong. The hidden prices, the thin review record, and up to 9 excluded states are what keep ReadyRx out of the 8s.
ReadyRx Cost Breakdown (2026)
Here is the wall you hit first. ReadyRx’s product pages list monthly plans, discounted quarterly plans, and one-time purchases — and every single price renders as $XXX until you sign up and hand over your details. We will call that what it is: a dark pattern. Companies with competitive prices publish them.
So the table below comes entirely from third-party pricing reports (Med Consumer Watch and Presidential GLP-1), not from ReadyRx’s own pages. That alone should annoy you.
| Medication | Reported price | 12-month math |
|---|---|---|
| Compounded semaglutide, month-to-month | $299/mo | $3,588/year |
| Compounded semaglutide, 3-month prepay | $249/mo ($747 per quarter) | $2,988/year |
| Compounded tirzepatide | $399/mo — no prepay discount | $4,788/year |
The structure underneath is actually customer-friendly. There is no membership or platform fee — the medication price bundles the consultation, unlimited provider messaging, and free expedited cold-chain shipping. Pricing is sold under an All Doses label, and third-party reviews confirm the price stays flat as your dose climbs. Med Consumer Watch also notes occasional first-month promos as low as $19.
The $XXX Problem
Do the prepay math. Committing to three months at a time saves $50 a month on semaglutide — $600 a year — but locks up $747 per charge. Tirzepatide gets no discount at all: $399 is the price whether you buy one month or twelve.
Now the absurd part. Rivals like MEDVi and OMZO advertise $179 first-month teasers that jump to $299 on refills — a 67% step-up. ReadyRx’s flat $299 is arguably the more honest number in that comparison. And yet ReadyRx is the one hiding it behind a signup form. A platform that makes you register to see a price is betting you won’t comparison shop. Comparison shop anyway.
What This ReadyRx Review Makes of the 5% Guarantee
The guarantee is the brand’s best weapon, and it is real: lose less than 5% of your baseline weight after 28 weeks of taking the medication as prescribed, and ReadyRx refunds your money. The company promoted it in a 2025-2026 press release. Very few platforms in our rankings put a refund in writing at all.
But read the clock before you count the money. 28 weeks is about 6.5 months. At $299/mo you will have paid roughly $2,093 before the guarantee can even trigger; at the $249 prepay rate you are near $1,750. And the fine print requires documented adherence — miss doses or check-ins, and you may not qualify.
One more honest note: a 5% bar is low by clinical standards. In the STEP 1 trial, FDA-approved semaglutide 2.4 mg averaged about 14.9% body-weight loss over 68 weeks. Most patients who stick with treatment clear 5% — which is exactly why a company can afford this promise. Treat it as a fair safety net, not free money.
What Customers Complain About — and What They Praise
Numbers first. ReadyRx’s Trustpilot score is reportedly excellent — 4.7 to 4.8 out of 5 — but it sits on a base of only about 65 reviews, per Med Consumer Watch’s February 2026-era count. For scale, TrimRx carries roughly 727 Trustpilot reviews and MEDVi’s BBB file alone logs 662 complaints. Sixty-five reviews is a rounding error. Read the 4.8 as promising, not proven.
The BBB picture is weaker. ReadyRx has a BBB presence with delivery and customer-service complaints on file, and it is not BBB accredited, per our research records. That is a far milder rap sheet than MEDVi’s F rating — but accreditation is a trust box that most platforms scoring 8+ on our list have ticked.
The documented praise is specific. Reviewers highlight approval within 24 hours for most applicants, pricing that does not creep upward with dose, and the lab paperwork: every compounded batch is third-party tested, with a certificate of analysis (COA) available on request. In a market the FDA has publicly warned about, a COA you can actually read is worth real money.
The complaints cluster around fulfillment and contact. Delivery hiccups sting more here because support is text-only — when a cold-shipped vial is late, there is no phone number to call and no video visit to book. You type into a message box and wait. For a $299-$399/mo product, some buyers will find that unacceptable.
How Ordering From ReadyRx Works
The process is asynchronous from start to finish. Five steps.
Step 1: The intake. You complete a short online health questionnaire — about 2 minutes, per the homepage. Signup is also the moment those $XXX placeholders finally become dollar figures.
Step 2: Provider review. A board-certified clinician reviews your file asynchronously. Third-party reviews report most approvals land within 24 hours. The consultation costs $0 extra — it is bundled into the medication price. But it is text-based: nobody phones you, ever.
Step 3: Pharmacy fulfillment. Prescriptions route to FDA-registered, state-licensed US compounding pharmacies, and ReadyRx is LegitScript-certified. The standout: an independent FDA- and DEA-registered lab tests each compounded batch for potency, sterility, pH, and endotoxicity, and patients can request the COA. The gap: ReadyRx does not disclose whether its pharmacies are 503A or 503B facilities. And once more for the record — these compounded drugs are not FDA-approved, a category the FDA has flagged specific concerns about.
Step 4: Delivery. Reviews report medication arriving within roughly 3-5 days of payment, shipped free, expedited, in cold storage, in discreet packaging.
Step 5: Ongoing care. Unlimited provider messaging is included, and subscriptions can reportedly be paused or canceled anytime — a friendlier exit than the prepaid lock-ins some rivals run.
Check your state before you start. Per third-party review data, compounded semaglutide is unavailable in 7 states (AR, KS, KY, LA, MS, NM, SC), and compounded tirzepatide is additionally blocked in California and North Carolina. That is roughly 43 states for semaglutide and 41 for tirzepatide — Californians who want tirzepatide are out entirely.
Set expectations with trial data, not testimonials. FDA-approved semaglutide averaged ~14.9% weight loss over 68 weeks in STEP 1; FDA-approved tirzepatide reached up to ~20.9% over 72 weeks in SURMOUNT-1. Compounded copies carry extra uncertainty by definition — that is the FDA’s point, not ours.
ReadyRx vs TrimRx
Our top alternative is TrimRx (7.8, Good), a San Diego platform whose flat-price tirzepatide is the best-known deal in this tier.
| ReadyRx | TrimRx | |
|---|---|---|
| Our score | 7.2 (Good) | 7.8 (Good) |
| Semaglutide | $299/mo; $249 with 3-month prepay (reported) | $199/mo (annual commitment); ~$349 month-to-month |
| Tirzepatide | $399/mo, no discount | $349/mo flat, all doses |
| Price transparency | $XXX until signup | Published, though some figures conflict |
| Guarantee | 5% at 28 weeks or refund, press-release documented | Conditional 3-month terms, unverified on site |
| Trustpilot | ~4.7/5 on ~65 reviews | ~3.3/5 on ~727 reviews |
On tirzepatide, TrimRx wins the sticker fight: $349 vs $399 is a $600-per-year gap, and both claim flat all-dose pricing. See how both stack up against the whole field in our best tirzepatide programs ranking, which compares final-dose costs across ten platforms.
Semaglutide is messier. TrimRx’s famous $199/mo demands a 12-month commitment; ReadyRx’s $249 asks for only three months at a time. If you refuse annual contracts, ReadyRx’s reported $249 beats TrimRx’s ~$349 month-to-month rate by $100 a month.
Trust is a genuine split decision. ReadyRx has the better score on a tiny base and the only documented refund guarantee; TrimRx has a big, polarized review base and a BBB file under review. What breaks the tie for us is transparency: TrimRx publishes numbers, ReadyRx makes you register to see one. That is most of the 0.6-point gap.
Final Verdict: Who Should Actually Buy
Buy ReadyRx if you want a refund policy in writing and lab receipts you can hold. The 5%-at-28-weeks guarantee is the most concrete money-back promise we have documented in this tier — unlike OMZO (6.9, Fair), whose lose-weight-or-your-money-back funnel is contradicted by non-refundable fine print in its own terms. Add flat $249-$299 semaglutide pricing that never rises with dose, COA lab testing, and 24-hour approvals, and ReadyRx is a rational pick for a self-directed buyer who never wants a phone call anyway. Men comparing no-fuss async programs on flat pricing can see the full field in our best GLP-1 for men ranking.
Skip ReadyRx if you live in one of the 7 to 9 excluded states, want a human voice on the line when a shipment goes sideways, or refuse — on principle — to hand over your details before seeing a price. And if you need a deep reputation record before spending $2,988+ a year, roughly 65 Trustpilot reviews will not get you there.
On our list, ReadyRx’s 7.2 sits just below MEDVi (7.6, Good), which publishes its $179 first-month price openly but drags an F BBB rating and 662 complaints behind it, and just above OMZO (6.9, Fair) with its contradictory guarantee. That is the mid-table in a nutshell: every platform here makes you trade something.
The bottom line of this ReadyRx review: a Good platform with the best guarantee and the worst price transparency in its weight class. The fix would cost ReadyRx nothing — print the prices. Until then, walk in armed with the third-party numbers above, screenshot your checkout total, and hold them to the 5% promise you signed up for.